Incontinence Care Products (ICP) Market

Incontinence Care Products (ICP) Market by Product (Absorbents (Bed Protectors, Pads & Guards), Non-absorbents (Catheters, Drainage Bags)), Usage (Reusable, Disposable), Distribution Channel (E-commerce), End User (Hospitals) & Region - Global Forecast to 2028

Report Code: MD 8789 Sep, 2023, by marketsandmarkets.com

The global incontinence care products market in terms of revenue was estimated to be worth $12.6 billion in 2023 and is poised to reach $16.5 billion by 2028, growing at a CAGR of 5.6% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Market growth is largely driven by the increasing geriatric population and subsequent rise in the prevalence of chronic medical conditions, coupled with rapid urbanization and rising disposable income.

On the other hand, the social stigma associated with incontinence care products restrain the growth of this market to a certain extent.

Attractive Opportunities in the Incontinence Care Products Market

Incontinence Care Products (ICP) Market

To know about the assumptions considered for the study, Request for Free Sample Report

Incontinence Care Products (ICP) Market

Incontinence Care Products Market Dynamics

DRIVER: Increasing geriatric population with chronic medical conditions

Incontinence is a common clinical problem, and its incidence is known to increase with age. Certain reports suggest that incontinence is mainly associated with frailty, whereby the ability of the body to cope with stress and physiological functions decreases. The World Health Organization (WHO) has identified incontinence as one of the priorities in the health field as it impacts the quality of life of the older population, leading to psychological, physical, and social consequences.

With the rapid increase in the aging population across the globe, urinary incontinence (UI) is a growing concern. In several large studies of women aged 50 years and above, nearly one-third to two-thirds of women in the US reported UI, while in the UK, it is estimated to affect around 30% to 40% of women. In a previous study for South Korea, UI was reported by 40.8% of female adults aged 30–79 years.

As per the WHO, by 2030, one in six people in the world will be aged above 60 years. The population aged 60 years and above will increase from 1 billion in 2020 to 1.4 billion in 2030. By 2050, this figure will approximately double (2.1 billion). The number of persons aged 80 years or older is anticipated to triple from 2020 and 2050 to reach nearly 426 million.

RESTRAINT: Social stigma associated with incontinence care products

People, especially women, often have to deal with the stigma associated with incontinence and the use of incontinence care products . The Essity 2020-21 survey revealed that 33% of respondents find incontinence the most difficult issue to talk about, even more so than issues such as depression and personal hygiene. It also indicates that incontinence remains a stigma in many parts of the world. While the stigma associated with depression, menstruation, and personal hygiene among women reduces with age, that associated with UI remains constant. Research shows that nearly one in three women in the UK have some form of weak bladder, but they do not address the same.

Stigma related to the use of incontinence care products, such as adult diapers, is very evident in certain countries. In India, for instance, cultural and societal norms identify urinary incontinence as a shameful and embarrassing condition. The reluctance to discuss or acknowledge urinary incontinence has resulted in an environment where adults requiring diapers are ashamed to seek the necessary assistance from family members or their doctors. Many women prefer to hide their condition, leading to social isolation and mental health problems. The lack of access to proper care and support can also cause physical discomfort and health issues.

OPPORTUNITY: Rising adoption of smart diapers

Superabsorbent polymers (SAPs) retain up to 1,000 times their weight in liquids and are used in applications that require high water absorption, quick solidification, and extended fluid retention. SAPs are utilized in a number of everyday products such as hot and cool packs, adult and baby diapers, absorbent and incontinence pads, and feminine hygiene products.

In the current market scenario, conventional SAPs used are non-biodegradable and hold a significant share of landfills across the globe. Hence, investments in the development of SAPs based on renewable materials are anticipated to create new opportunities for the global market. SAPs made of renewable materials are a suitable alternative to petrochemical-based polymers, such as sodium polyacrylate and potassium polyacrylate, currently used in disposable diapers’ absorbent core, among other personal hygiene products.

CHALLENGE: Disparities in reimbursement for incontinence care products

Patients of incontinence generally do not receive reimbursement for absorbent incontinence products. In the US, Incontinence supplies for seniors who qualify for Medicaid may be partially to completely reimbursed. Currently, 45 states and Washington, DC offer some level of reimbursement for absorbent incontinence products. However, Medicare reimbursement coverage allows intermittent catheter (IC) users to be reimbursed for a maximum of 200 sterile, single-use catheters per month.

In Germany, a minimum of 0.2% of the total expenditure of health insurances is allocated to incontinence products such as briefs, pads, or pants. The regulatory process and public-private insurance systems related to incontinence care products are not well-developed in these countries. Hence, manufacturers face challenges targeting countries with a single approach; customized approaches must be followed for greater market penetration.

Incontinence Care Products Ecosystem/Market Map

Incontinence Care Products (ICP) Market Ecosystem

Absorbents segment accounted for the largest share of the incontinence care products industry in 2022, by product type

Based on product type, the incontinence care products market is segmented into absorbents and non-absorbents. Absorbents accounted for the market’s larger share (67.9%) in 2022. This can primarily be attributed to better ease of use and enhanced leakage coverage, and ease of use. Unlike UTI that is caused by the use of catheters, absorbents such as diapers cause less harm to the patients and are associated with less complications.

Females segment accounted for the largest share in the incontinence care products industry in 2022, by gender

On the basis of gender, the global incontinence care products market is categorized into females and males. In 2022, the female segment held the largest share in the market, by gender. The growth of the segment can be attributed to the high incidence of urinary incontinence among women.

Disposable segment accounted for the largest share in the incontinence care products industry in 2022, by usage

Based on usage, the incontinence care products market is segmented into disposable and reusable. In 2022, the disposable segment accounted for the larger share (82.1%) of the ICP market. This segment is also projected to register the higher CAGR during the forecast period due to the rising demand for single-use products such for the management of urinary incontinence.

Europe accounted for the largest share of the incontinence care products industry in 2022

The incontinence care products market is segmented into four major regions: North America, Europe, the Asia Pacific, and the Rest of the World. In 2022, Europe emerged as the leading contributor, claiming the largest portion of the market share in the incontinence care products industry. With the presence of major players in the region, Europe has witnessed various advancements in the field of incontinence care products. These companies have expertise, resources, and well-established sales networks, contributing to the region’s market dominance. Examples of prominent incontinence care products companies in Europe include Essity Aktiebolag (publ) (Sweden) and HARTMANN (Germany).

Incontinence Care Products (ICP) Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The major players in incontinence care products market are Essity Aktiebolag (publ) (Sweden), The Procter & Gamble Company (US), and Kimberly-Clark Corporation (US), HARTMANN (Germany), and Ontex BV (Belgium). These players’ market leadership is due to their comprehensive product portfolios and expansive global footprint. These dominant market players have several advantages, including strong research and development budgets, strong marketing and distribution networks, and well-established brand recognition.

Scope of the Incontinence Care Products Industry:

Report Metric

Details

Market Revenue in 2023

$12.6 billion

Estimated Value by 2028

$16.5 billion

Revenue Rate

Poised to grow at a CAGR of 5.6%

Market Driver

Increasing geriatric population with chronic medical conditions

Market Opportunity

Rising adoption of smart diapers

This research report categorizes the Incontinence Care Products Market to forecast revenue and analyze trends in each of the following submarkets:

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

By Product Type

  • Absorbents
  • Non-absorbents

By Usage

  • Disposable
  • Reusable

By Gender

  • Female
  • Male

By Distribution Channel

  • E-commerce
  • Retailer Pharmacies
  • Hospital Pharmacies

By End User

  • Home-based Patients
  • Hospitals & Ambulatory Surgical Centers (ASCs)
  • Other End Users

Recent Developments of Incontinence Care Products Industry

  • In May 2023, Cardinal Health established a distribution center in the Greater Toronto Area (GTA) to meet the Canadian healthcare system's medical and surgical product demands.
  • In February 2023, Medline partnered with Synthase Collaborative. As part of the partnership, Medline will be the primary supplier of essential medical supplies, including incontinence care products and general nursing supplies to Synthase’s member organizations — Avow, Treasure Coast Hospice, St. Francis Reflections Lifestage Care, and Haven
  • In September 2022, Attindas Hygiene Partners announced its innovative new adult disposable incontinence underwear product in North America.
  • In July 2022, Essity acquired 80% of the Canadian company Knix, a leading provider of leakproof apparel for periods and incontinence. Post-acquisition, Essity is regarded among the market leaders in the leakproof apparel industry.
  • In April 2022, Kimberly-Clark Corporation launched New Poise Ultra Thin Pads with Wings for bladder leaks under the Poise brand.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 30)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
                    FIGURE 1 INCONTINENCE CARE PRODUCTS MARKET SEGMENTATION
           1.3.2 GEOGRAPHICAL SCOPE
           1.3.3 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 MARKET STAKEHOLDERS 
 
2 RESEARCH METHODOLOGY (Page No. - 33)
    2.1 RESEARCH APPROACH 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY RESEARCH
                    2.1.2.1 Primary sources
                    2.1.2.2 Key data from primary sources
                    2.1.2.3 Key industry insights
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 5 REVENUE SHARE ANALYSIS
          FIGURE 6 PATIENT-BASED ANALYSIS
          FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF MARKET
          FIGURE 8 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS 
    2.5 STUDY ASSUMPTIONS 
    2.6 RESEARCH LIMITATIONS 
    2.7 RISK ASSESSMENT 
          TABLE 1 RISK ASSESSMENT: MARKET
    2.8 GROWTH RATE ASSUMPTIONS 
    2.9 IMPACT OF RECESSION ON MARKET 
 
3 EXECUTIVE SUMMARY (Page No. - 46)
    FIGURE 10 INCONTINENCE CARE PRODUCTS MARKET, BY PRODUCT TYPE, 2023 VS. 2028 (USD BILLION)
    FIGURE 11 MARKET, BY GENDER, 2023 VS. 2028 (USD BILLION)
    FIGURE 12 MARKET, BY USAGE, 2023 VS. 2028 (USD BILLION)
    FIGURE 13 MARKET, BY DISTRIBUTION CHANNEL, 2023 VS. 2028 (USD BILLION)
    FIGURE 14 MARKET, BY END USER, 2023 VS. 2028 (USD BILLION)
    FIGURE 15 GEOGRAPHICAL SNAPSHOT: MARKET
 
4 PREMIUM INSIGHTS (Page No. - 51)
    4.1 INCONTINENCE CARE PRODUCTS MARKET OVERVIEW 
          FIGURE 16 INCREASING GERIATRIC POPULATION AND RISING PREVALENCE OF INCONTINENCE TO DRIVE MARKET GROWTH IN FORECAST PERIOD
    4.2 EUROPE: MARKET, BY PRODUCT (2022) 
          FIGURE 17 HOME-BASED PATIENTS SEGMENT LED MARKET IN 2022
    4.3 GEOGRAPHICAL GROWTH OPPORTUNITIES IN MARKET 
          FIGURE 18 CHINA AND INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
    4.4 MARKET: GEOGRAPHICAL MIX 
          FIGURE 19 ASIA PACIFIC TO RECORD HIGHEST GROWTH DURING FORECAST PERIOD
    4.5 MARKET: DEVELOPED VS. DEVELOPING MARKETS 
          FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 55)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 21 INCONTINENCE CARE PRODUCTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing geriatric population with chronic medical conditions
                                TABLE 2 COUNTRIES WITH LARGE GERIATRIC POPULATION, 2021 AND 2050
                    5.2.1.2 Significant prevalence of incontinence
                                TABLE 3 GLOBAL PREVALENCE OF URINARY INCONTINENCE AMONG OLDER WOMEN
                    5.2.1.3 Growing attention to personal hygiene
                    5.2.1.4 Rapid urbanization and rising disposable income
           5.2.2 RESTRAINTS
                    5.2.2.1 Social stigma associated with incontinence care products
                    5.2.2.2 Environmental concerns related to disposal of incontinence products
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Development of bio-based superabsorbent polymers
                    5.2.3.2 Rising adoption of smart diapers
           5.2.4 CHALLENGES
                    5.2.4.1 Underreporting of fecal incontinence
                    5.2.4.2 Disparities in reimbursement for incontinence care products
    5.3 VALUE CHAIN ANALYSIS 
          FIGURE 22 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDITION IN MANUFACTURING AND ASSEMBLY PHASES
    5.4 SUPPLY CHAIN ANALYSIS 
          FIGURE 23 PROMINENT COMPANIES TO OPT FOR DIRECT DISTRIBUTION STRATEGY
    5.5 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 4 HIGH CONSOLIDATION IN MARKET TO RESTRICT ENTRY OF NEW PLAYERS
           5.5.1 DEGREE OF COMPETITION
           5.5.2 BARGAINING POWER OF SUPPLIERS
           5.5.3 BARGAINING POWER OF BUYERS
           5.5.4 THREAT FROM SUBSTITUTES
           5.5.5 THREAT FROM NEW ENTRANTS
    5.6 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
                    FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
                    TABLE 5 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
           5.6.2 BUYING CRITERIA
                    FIGURE 25 KEY BUYING CRITERIA FOR MAJOR END USERS
                    TABLE 6 KEY BUYING CRITERIA, BY END USER
    5.7 REGULATORY LANDSCAPE 
           5.7.1 NORTH AMERICA
                    5.7.1.1 US
                    5.7.1.2 Canada
           5.7.2 EUROPE
           5.7.3 ASIA PACIFIC
                    5.7.3.1 China
                    5.7.3.2 Japan
                    5.7.3.3 India
                    5.7.3.4 South Korea
           5.7.4 LATIN AMERICA
                    5.7.4.1 Brazil
                    5.7.4.2 Mexico
           5.7.5 MIDDLE EAST
           5.7.6 AFRICA
    5.8 TECHNOLOGY ANALYSIS 
    5.9 TRADE ANALYSIS 
           5.9.1 TRADE ANALYSIS FOR INCONTINENCE CARE PRODUCTS (ABSORBENTS)
                    TABLE 7 IMPORT DATA FOR HS CODE 961900, BY COUNTRY, 2018–2022 (USD MILLION)
                    TABLE 8 EXPORT DATA FOR HS CODE 961900, BY COUNTRY, 2018–2022 (USD MILLION)
           5.9.2 TRADE ANALYSIS FOR INCONTINENCE CARE PRODUCTS (NON-ABSORBENTS)
                    TABLE 9 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018–2022 (USD MILLION)
                    TABLE 10 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018–2022 (USD MILLION)
    5.10 ECOSYSTEM ANALYSIS 
           FIGURE 26 ECOSYSTEM ANALYSIS
           FIGURE 27 ECOSYSTEM MAP
           5.10.1 ROLE IN ECOSYSTEM
    5.11 PATENT ANALYSIS 
           5.11.1 PATENT ANALYSIS FOR INCONTINENCE CARE
                    5.11.1.1 Granted patent publication trends
                                 FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2013–DECEMBER 2022)
           5.11.2 PATENT ANALYSIS FOR INCONTINENCE CARE (JANUARY 2013–DECEMBER 2022)
    5.12 KEY CONFERENCES AND EVENTS, 2023–2024 
           TABLE 11 CONFERENCES AND EVENTS, 2023–2024
    5.13 PRICING ANALYSIS 
           5.13.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
                     TABLE 12 PRICE RANGE OF PRODUCTS OFFERED BY KEY PLAYERS (USD)
    5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
 
6 INCONTINENCE CARE PRODUCTS MARKET, BY PRODUCT TYPE (Page No. - 74)
    6.1 INTRODUCTION 
          TABLE 13 INCONTINENCE CARE PRODUCTS INDUSTRY, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
    6.2 ABSORBENTS 
          TABLE 14 MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 15 MARKET, BY TYPE, 2021–2028 (USD MILLION)
           6.2.1 PADS & GUARDS  
                    6.2.1.1 Ease of use to drive market
                                TABLE 16 PADS & GUARDS: MARKET, BY REGION, 2021–2028 (USD MILLION)
           6.2.2 UNDERWEAR & BRIEFS  
                    6.2.2.1 Increased absorbency to drive demand
                                TABLE 17 UNDERWEAR & BRIEFS: MARKET, BY REGION, 2021–2028 (USD MILLION)
           6.2.3 BED PROTECTORS  
                    6.2.3.1 Rising demand from patients to boost market
                                TABLE 18 BED PROTECTORS: MARKET, BY REGION, 2021–2028 (USD MILLION)
           6.2.4 OTHER ABSORBENTS  
                    TABLE 19 OTHER ABSORBENTS: MARKET, BY REGION, 2021–2028 (USD MILLION)
    6.3 NON-ABSORBENTS 
          TABLE 20 NON-ABSORBENTS: MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 21 NON-ABSORBENTS: MARKET, BY TYPE, 2021–2028 (USD MILLION)
           6.3.1 CATHETERS
                    6.3.1.1 Rising need for efficient bladder control to drive demand
                                TABLE 22 CATHETERS: MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 23 CATHETERS: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    6.3.1.2 Intermittent catheters
                               6.3.1.2.1 Reduced risk of infections to boost market
                                              TABLE 24 INTERMITTENT CATHETERS: MARKET, BY REGION, 2021–2028 (USD MILLION)
                    6.3.1.3 Indwelling catheters
                               6.3.1.3.1 Rising usage by critically ill patients to drive demand
                                              TABLE 25 INDWELLING CATHETERS: MARKET, BY REGION, 2021–2028 (USD MILLION)
                    6.3.1.4 External catheters
                               6.3.1.4.1 Ease of use to boost demand
                                              TABLE 26 EXTERNAL CATHETERS: MARKET, BY REGION, 2021–2028 (USD MILLION)
           6.3.2 DRAINAGE BAGS
                    6.3.2.1 Rising demand to propel market growth
                                TABLE 27 DRAINAGE BAGS: MARKET, BY REGION, 2021–2028 (USD MILLION)
           6.3.3 STIMULATION DEVICES
                    6.3.3.1 Growing use in home settings to drive market
                                TABLE 28 STIMULATION DEVICES: MARKET, BY REGION, 2021–2028 (USD MILLION)
           6.3.4 OTHER NON-ABSORBENTS
                    TABLE 29 OTHER NON-ABSORBENTS: MARKET, BY REGION, 2021–2028 (USD MILLION)
 
7 INCONTINENCE CARE PRODUCTS MARKET, BY USAGE (Page No. - 87)
    7.1 INTRODUCTION 
          TABLE 30 INCONTINENCE CARE PRODUCTS INDUSTRY, BY USAGE, 2021–2028 (USD MILLION)
    7.2 DISPOSABLE 
           7.2.1 EASY AVAILABILITY AND CONVENIENCE TO DRIVE MARKET
                    TABLE 31 DISPOSABLE: MARKET, BY REGION, 2021–2028 (USD MILLION)
    7.3 REUSABLE 
           7.3.1 ENVIRONMENTAL FRIENDLINESS TO DRIVE DEMAND
                    TABLE 32 REUSABLE: MARKET, BY REGION, 2021–2028 (USD MILLION)
 
8 INCONTINENCE CARE PRODUCTS MARKET, BY GENDER (Page No. - 90)
    8.1 INTRODUCTION 
          TABLE 33 INCONTINENCE CARE PRODUCTS INDUSTRY, BY GENDER, 2021–2028 (USD MILLION)
    8.2 FEMALE 
           8.2.1 HIGHER RATE OF INCONTINENCE AMONG WOMEN TO DRIVE MARKET
                    TABLE 34 FEMALE: MARKET, BY REGION, 2021–2028 (USD MILLION)
    8.3 MALE 
           8.3.1 RISING PREVALENCE OF BPH TO PROPEL MARKET GROWTH
                    TABLE 35 MALE: MARKET, BY REGION, 2021–2028 (USD MILLION)
 
9 INCONTINENCE CARE PRODUCTS MARKET, BY DISTRIBUTION CHANNEL (Page No. - 93)
    9.1 INTRODUCTION 
          TABLE 36 INCONTINENCE CARE PRODUCTS INDUSTRY, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
    9.2 E-COMMERCE 
           9.2.1 PREFERENCE FOR DIRECT DISTRIBUTION CHANNELS TO DRIVE MARKET
                    TABLE 37 E-COMMERCE: MARKET, BY REGION, 2021–2028 (USD MILLION)
    9.3 RETAILER PHARMACIES 
           9.3.1 EASY ACCESS TO PRODUCTS TO BOOST MARKET
                    TABLE 38 RETAILER PHARMACIES: MARKET, BY REGION, 2021–2028 (USD MILLION)
    9.4 HOSPITAL PHARMACIES 
           9.4.1 HIGH PATIENT CONVENIENCE TO DRIVE DEMAND
                    TABLE 39 HOSPITAL PHARMACIES: MARKET, BY REGION, 2021–2028 (USD MILLION)
 
10 INCONTINENCE CARE PRODUCTS MARKET, BY END USER (Page No. - 97)
     10.1 INTRODUCTION 
             TABLE 40 INCONTINENCE CARE PRODUCTS INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
     10.2 HOME-BASED PATIENTS 
             10.2.1 INCREASING GERIATRIC POPULATION TO DRIVE DEMAND
                        TABLE 41 HOME-BASED PATIENTS: MARKET, BY REGION, 2021–2028 (USD MILLION)
     10.3 HOSPITALS & AMBULATORY SURGICAL CENTERS (ASCS) 
             10.3.1 RISING NUMBER OF SURGERIES TO PROPEL MARKET GROWTH
                        TABLE 42 HOSPITALS & ASCS: MARKET, BY REGION, 2021–2028 (USD MILLION)
     10.4 OTHER END USERS 
             TABLE 43 OTHER END USERS: MARKET, BY REGION, 2021–2028 (USD MILLION)
 
11 INCONTINENCE CARE PRODUCTS MARKET, BY REGION (Page No. - 101)
     11.1 INTRODUCTION 
             TABLE 44 INCONTINENCE CARE PRODUCTS INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
     11.2 EUROPE 
             FIGURE 29 EUROPE: MARKET SNAPSHOT
             TABLE 45 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 46 EUROPE: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
             TABLE 47 EUROPE: ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 48 EUROPE: NON-ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 49 EUROPE: CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 50 EUROPE: MARKET, BY GENDER, 2021–2028 (USD MILLION)
             TABLE 51 EUROPE: MARKET, BY USAGE, 2021–2028 (USD MILLION)
             TABLE 52 EUROPE: MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
             TABLE 53 EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.1 IMPACT OF ECONOMIC RECESSION ON EUROPE
             11.2.2 GERMANY
                        11.2.2.1 Growing incidence of neurological conditions to propel demand
                                      TABLE 54 GERMANY: INCONTINENCE CARE PRODUCTS MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                      TABLE 55 GERMANY: ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 56 GERMANY: NON-ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 57 GERMANY: CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 58 GERMANY: MARKET, BY GENDER, 2021–2028 (USD MILLION)
                                      TABLE 59 GERMANY: MARKET, BY USAGE, 2021–2028 (USD MILLION)
                                      TABLE 60 GERMANY: MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
                                      TABLE 61 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.3 UK
                        11.2.3.1 High prevalence of chronic diseases to accelerate demand
                                      TABLE 62 UK: INCONTINENCE CARE PRODUCTS MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                      TABLE 63 UK: ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 64 UK: NON-ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 65 UK: CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 66 UK: MARKET, BY GENDER, 2021–2028 (USD MILLION)
                                      TABLE 67 UK: MARKET, BY USAGE, 2021–2028 (USD MILLION)
                                      TABLE 68 UK: MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
                                      TABLE 69 UK: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.4 ITALY
                        11.2.4.1 Favorable healthcare reimbursement scenario to fuel market growth
                                      TABLE 70 ITALY: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                      TABLE 71 ITALY: ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 72 ITALY: NON-ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 73 ITALY: CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 74 ITALY: MARKET, BY GENDER, 2021–2028 (USD MILLION)
                                      TABLE 75 ITALY: MARKET, BY USAGE, 2021–2028 (USD MILLION)
                                      TABLE 76 ITALY: MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
                                      TABLE 77 ITALY: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.5 FRANCE
                        11.2.5.1 Large target population to support market growth
                                      TABLE 78 FRANCE: INCONTINENCE CARE PRODUCTS MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                      TABLE 79 FRANCE: ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 80 FRANCE: NON-ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 81 FRANCE: CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 82 FRANCE: MARKET, BY GENDER, 2021–2028 (USD MILLION)
                                      TABLE 83 FRANCE: MARKET, BY USAGE, 2021–2028 (USD MILLION)
                                      TABLE 84 FRANCE: MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
                                      TABLE 85 FRANCE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.6 SPAIN
                        11.2.6.1 Rising prevalence of chronic disorders to drive market growth
                                      TABLE 86 SPAIN: INCONTINENCE CARE PRODUCTS MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                      TABLE 87 SPAIN: ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 88 SPAIN: NON-ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 89 SPAIN: CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 90 SPAIN: MARKET, BY GENDER, 2021–2028 (USD MILLION)
                                      TABLE 91 SPAIN: MARKET, BY USAGE, 2021–2028 (USD MILLION)
                                      TABLE 92 SPAIN: MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
                                      TABLE 93 SPAIN: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.7 REST OF EUROPE
                        TABLE 94 REST OF EUROPE: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                        TABLE 95 REST OF EUROPE: ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 96 REST OF EUROPE: NON-ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 97 REST OF EUROPE: CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 98 REST OF EUROPE: MARKET, BY GENDER, 2021–2028 (USD MILLION)
                        TABLE 99 REST OF EUROPE: MARKET, BY USAGE, 2021–2028 (USD MILLION)
                        TABLE 100 REST OF EUROPE: MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
                        TABLE 101 REST OF EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
     11.3 NORTH AMERICA 
             TABLE 102 NORTH AMERICA: INCONTINENCE CARE PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 103 NORTH AMERICA: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
             TABLE 104 NORTH AMERICA: ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 105 NORTH AMERICA: NON-ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 106 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 107 NORTH AMERICA: MARKET, BY GENDER, 2021–2028 (USD MILLION)
             TABLE 108 NORTH AMERICA: MARKET, BY USAGE, 2021–2028 (USD MILLION)
             TABLE 109 NORTH AMERICA: MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
             TABLE 110 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.1 IMPACT OF ECONOMIC RECESSION ON NORTH AMERICA
             11.3.2 US
                        11.3.2.1 Rising prevalence of incontinence to drive market
                                      TABLE 111 US: INCONTINENCE CARE PRODUCTS MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                      TABLE 112 US: ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 113 US: NON-ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 114 US: CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 115 US: MARKET, BY GENDER, 2021–2028 (USD MILLION)
                                      TABLE 116 US: MARKET, BY USAGE, 2021–2028 (USD MILLION)
                                      TABLE 117 US: MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
                                      TABLE 118 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.3 CANADA
                        11.3.3.1 Increasing geriatric population to drive demand
                                      TABLE 119 CANADA: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                      TABLE 120 CANADA: ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 121 CANADA: NON-ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 122 CANADA: CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 123 CANADA: MARKET, BY GENDER, 2021–2028 (USD MILLION)
                                      TABLE 124 CANADA: MARKET, BY USAGE, 2021–2028 (USD MILLION)
                                      TABLE 125 CANADA: MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
                                      TABLE 126 CANADA: MARKET, BY END USER, 2021–2028 (USD MILLION)
     11.4 ASIA PACIFIC 
             FIGURE 30 ASIA PACIFIC: INCONTINENCE CARE PRODUCTS MARKET SNAPSHOT
             TABLE 127 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 128 ASIA PACIFIC: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
             TABLE 129 ASIA PACIFIC: ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 130 ASIA PACIFIC: NON-ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 131 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 132 ASIA PACIFIC: MARKET, BY GENDER, 2021–2028 (USD MILLION)
             TABLE 133 ASIA PACIFIC: MARKET, BY USAGE, 2021–2028 (USD MILLION)
             TABLE 134 ASIA PACIFIC: MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
             TABLE 135 ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.1 IMPACT OF ECONOMIC RECESSION ON ASIA PACIFIC
             11.4.2 CHINA
                        11.4.2.1 Rapidly increasing elderly population to boost demand
                                      TABLE 136 CHINA: INCONTINENCE CARE PRODUCTS MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                      TABLE 137 CHINA: ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 138 CHINA: NON-ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 139 CHINA: CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 140 CHINA: MARKET, BY GENDER, 2021–2028 (USD MILLION)
                                      TABLE 141 CHINA: MARKET, BY USAGE, 2021–2028 (USD MILLION)
                                      TABLE 142 CHINA: MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
                                      TABLE 143 CHINA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.3 JAPAN
                        11.4.3.1 Private sector initiatives to drive market
                                      TABLE 144 JAPAN: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                      TABLE 145 JAPAN: ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 146 JAPAN: NON-ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 147 JAPAN: CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 148 JAPAN: MARKET, BY GENDER, 2021–2028 (USD MILLION)
                                      TABLE 149 JAPAN: MARKET, BY USAGE, 2021–2028 (USD MILLION)
                                      TABLE 150 JAPAN: MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
                                      TABLE 151 JAPAN: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.4 INDIA
                        11.4.4.1 Indigenous development of innovative products to boost market
                                      TABLE 152 INDIA: INCONTINENCE CARE PRODUCTS MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                      TABLE 153 INDIA: ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 154 INDIA: NON-ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 155 INDIA: CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 156 INDIA: MARKET, BY GENDER, 2021–2028 (USD MILLION)
                                      TABLE 157 INDIA: MARKET, BY USAGE, 2021–2028 (USD MILLION)
                                      TABLE 158 INDIA: MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
                                      TABLE 159 INDIA: MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.5 REST OF ASIA PACIFIC
                        TABLE 160 REST OF ASIA PACIFIC: INCONTINENCE CARE PRODUCTS MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                        TABLE 161 REST OF ASIA PACIFIC: ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 162 REST OF ASIA PACIFIC: NON-ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 163 REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 164 REST OF ASIA PACIFIC: MARKET, BY GENDER, 2021–2028 (USD MILLION)
                        TABLE 165 REST OF ASIA PACIFIC: MARKET, BY USAGE, 2021–2028 (USD MILLION)
                        TABLE 166 REST OF ASIA PACIFIC: MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
                        TABLE 167 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
     11.5 REST OF THE WORLD 
             11.5.1 RISING PREVALENCE OF CHRONIC CONDITIONS TO PROPEL DEMAND
             11.5.2 IMPACT OF ECONOMIC RECESSION ON REST OF THE WORLD
                        TABLE 168 REST OF THE WORLD: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                        TABLE 169 REST OF THE WORLD: ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 170 REST OF THE WORLD: NON-ABSORBENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 171 REST OF THE WORLD: CATHETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 172 REST OF THE WORLD: MARKET, BY GENDER, 2021–2028 (USD MILLION)
                        TABLE 173 REST OF THE WORLD: MARKET, BY USAGE, 2021–2028 (USD MILLION)
                        TABLE 174 REST OF THE WORLD: MARKET, BY DISTRIBUTION CHANNEL, 2021–2028 (USD MILLION)
                        TABLE 175 REST OF THE WORLD: MARKET, BY END USER, 2021–2028 (USD MILLION)
 
12 COMPETITIVE LANDSCAPE (Page No. - 162)
     12.1 OVERVIEW 
     12.2 STRATEGIES OF KEY PLAYERS 
             12.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY MARKET PLAYERS
                        TABLE 176 OVERVIEW OF STRATEGIES ADOPTED BY KEY INCONTINENCE CARE PRODUCT MANUFACTURERS
     12.3 REVENUE ANALYSIS OF TOP MARKET PLAYERS 
             FIGURE 31 REVENUE ANALYSIS OF TOP MARKET PLAYERS
     12.4 MARKET SHARE ANALYSIS 
             TABLE 177 INCONTINENCE CARE PRODUCTS MARKET: DEGREE OF COMPETITION
             FIGURE 32 INCONTINENCE CARE PRODUCTS INDUSTRY SHARE, BY KEY PLAYER (2022)
     12.5 COMPANY EVALUATION MATRIX 
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
                        FIGURE 33 INCONTINENCE CARE PRODUCTS INDUSTRY: COMPANY EVALUATION QUADRANT
     12.6 COMPANY EVALUATION MATRIX (SMES/STARTUPS) 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 STARTING BLOCKS
             12.6.3 RESPONSIVE COMPANIES
             12.6.4 DYNAMIC COMPANIES
                        FIGURE 34 MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES
     12.7 COMPETITIVE BENCHMARKING 
             TABLE 178 MARKET: KEY STARTUPS/SMES
     12.8 COMPANY FOOTPRINT ANALYSIS 
             TABLE 179 COMPANY FOOTPRINT
             TABLE 180 COMPANY PRODUCT FOOTPRINT
             TABLE 181 COMPANY REGIONAL FOOTPRINT
     12.9 COMPETITIVE SCENARIO 
             12.9.1 PRODUCT LAUNCHES & APPROVALS
                        TABLE 182 INCONTINENCE CARE PRODUCTS INDUSTRY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020–JULY 2023
             12.9.2 DEALS
                        TABLE 183 INCONTINENCE CARE PRODUCTS INDUSTRY: DEALS, JANUARY 2020–JULY 2023
             12.9.3 OTHER DEVELOPMENTS
                        TABLE 184 INCONTINENCE CARE PRODUCTS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–JULY 2023
 
13 COMPANY PROFILES (Page No. - 174)
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
     13.1 KEY PLAYERS 
             13.1.1 ESSITY AKTIEBOLAG (PUBL)
                        TABLE 185 ESSITY AKTIEBOLAG (PUBL): BUSINESS OVERVIEW
                        FIGURE 35 ESSITY AKTIEBOLAG (PUBL): COMPANY SNAPSHOT (2022)
             13.1.2 KIMBERLY-CLARK CORPORATION
                        TABLE 186 KIMBERLY-CLARK CORPORATION: BUSINESS OVERVIEW
                        FIGURE 36 KIMBERLY-CLARK CORPORATION: COMPANY SNAPSHOT (2022)
             13.1.3 THE PROCTER & GAMBLE COMPANY
                        TABLE 187 THE PROCTER & GAMBLE COMPANY: BUSINESS OVERVIEW
                        FIGURE 37 THE PROCTER & GAMBLE COMPANY: COMPANY SNAPSHOT (2022)
             13.1.4 HARTMANN
                        TABLE 188 HARTMANN: BUSINESS OVERVIEW
                        FIGURE 38 HARTMANN: COMPANY SNAPSHOT (2022)
             13.1.5 ONTEX BV
                        TABLE 189 ONTEX BV: BUSINESS OVERVIEW
                        FIGURE 39 ONTEX BV: COMPANY SNAPSHOT (2022)
             13.1.6 UNICHARM CORPORATION
                        TABLE 190 UNICHARM CORPORATION: BUSINESS OVERVIEW
                        FIGURE 40 UNICHARM CORPORATION: COMPANY SNAPSHOT (2022)
             13.1.7 COLOPLAST A/S
                        TABLE 191 COLOPLAST A/S: BUSINESS OVERVIEW
                        FIGURE 41 COLOPLAST A/S: COMPANY SNAPSHOT (2022)
             13.1.8 CARDINAL HEALTH, INC.
                        TABLE 192 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
                        FIGURE 42 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022)
             13.1.9 MEDLINE INDUSTRIES, LP
                        TABLE 193 MEDLINE INDUSTRIES, LP: BUSINESS OVERVIEW
             13.1.10 MCKESSON CORPORATION
                        TABLE 194 MCKESSON CORPORATION: BUSINESS OVERVIEW
                        FIGURE 43 MCKESSON CORPORATION: COMPANY SNAPSHOT (2023)
             13.1.11 ABENA
                        TABLE 195 ABENA: BUSINESS OVERVIEW
                        FIGURE 44 ABENA: COMPANY SNAPSHOT (2022)
             13.1.12 ATTINDAS HYGIENE PARTNERS GROUP
                        TABLE 196 ATTINDAS HYGIENE PARTNERS GROUP: BUSINESS OVERVIEW
             13.1.13 HOLLISTER INCORPORATED
                        TABLE 197 HOLLISTER INCORPORATED: BUSINESS OVERVIEW
             13.1.14 DYNAREX CORPORATION
                        TABLE 198 DYNAREX CORPORATION: BUSINESS OVERVIEW
     13.2 OTHER PLAYERS 
             13.2.1 CONVATEC GROUP PLC
                        TABLE 199 CONVATEC GROUP PLC: BUSINESS OVERVIEW
             13.2.2 BECTON, DICKINSON AND COMPANY
                        TABLE 200 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
             13.2.3 WELLSPECT HEALTHCARE
                        TABLE 201 WELLSPECT HEALTHCARE: BUSINESS OVERVIEW
             13.2.4 STRYKER
                        TABLE 202 STRYKER: BUSINESS OVERVIEW
             13.2.5 FIRST QUALITY ENTERPRISES, INC.
                        TABLE 203 FIRST QUALITY ENTERPRISES, INC.: BUSINESS OVERVIEW
             13.2.6 PRINCIPLE BUSINESS ENTERPRISES, INC.
                        TABLE 204 PRINCIPLE BUSINESS ENTERPRISES, INC.: BUSINESS OVERVIEW
             13.2.7 TZMO SA
                        TABLE 205 TZMO SA: BUSINESS OVERVIEW
             13.2.8 PRIMARE INTERNATIONAL LTD.
                        TABLE 206 PRIMARE INTERNATIONAL LTD.: BUSINESS OVERVIEW
             13.2.9 DRYLOCK TECHNOLOGIES
                        TABLE 207 DRYLOCK TECHNOLOGIES: BUSINESS OVERVIEW
             13.2.10 NORTHSHORE CARE SUPPLY
                        TABLE 208 NORTHSHORE CARE SUPPLY: BUSINESS OVERVIEW
             13.2.11 NOBEL HYGIENE
                        TABLE 209 NOBEL HYGIENE: BUSINESS OVERVIEW
 
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
 
14 APPENDIX (Page No. - 216)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS 

The objective of the study is analyze the key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies. To track companies developments such as product launches and approvals, expansions, and partnerships of the leading players, the competitive landscape of the incontinence care products market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were use to estimate the market size. To estimate the market size of segments and subsegments the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Collecting Secondary Data

The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was conducted after acquiring knowledge about the market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as doctors, nurses, and hospital purchase managers) and supply-side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Participants:

Incontinence Care Products (ICP) Market Size, and Share

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2: Tiers are defined based on a company’s total revenue. As of 2022: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

The Procter & Gamble Company (US)

Business Manager

Dynarex Corporation (US)

VP Marketing

Essity Aktiebolag (publ) (Sweden)

Senior Director

Unicharm Corporation (Japan)

Regional Sales Head

Market Size Estimation

All major product manufacturers offering various incontinence care products were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value incontinence care products market was also split into various segments and subsegments at the region and country level based on:

  • Product mapping of various manufacturers for each type of market at the regional and country-level
  • Relative adoption pattern of each market among key application segments at the regional and/or country-level
  • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level.
  • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level

Global Incontinence Care Products Market Size: Botton Up Approach

Incontinence Care Products (ICP) Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Incontinence Care Products Market Size: Top Down Approach

Incontinence Care Products (ICP) Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the incontinence care products industry.

Market Definition

Incontinence refers to an involuntary loss of urine or feces, which occurs due to problems with the muscles and nerves of the bladder or bowel. Urinary incontinence is defined as the loss of urine from the bladder, while fecal incontinence refers to the involuntary loss of feces from the bowel. Stress, urge, mixed, overflow, and functional incontinence are some of the most commonly occurring types of urine and bowel incontinence, observed usually in the elderly population or in patients with certain illnesses.

Key Stakeholders

  • Senior Management
  • End User
  • Finance/Procurement Department
  • R&D Department

Report Objectives

  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To define, describe, segment, and forecast the incontinence care products market by product type, usage, gender, distribution channel, end user, and region
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To forecast the size of the market in four main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific and Rest of the World
  • To profile key players in the market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as product launches and approvals; expansions; and partnerships; of the leading players in the market
  • To benchmark players within the market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

MarketsandMarkets offers the following customizations for this market report

Country Information

  • Additional country-level analysis of the incontinence care products market

Company profiles

  • Additional three company profiles of players operating in the incontinence care products market.

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the incontinence care products market
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
MD 8789
Published ON
Sep, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Incontinence Care Products (ICP) Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback